|
|
||||||||
The Journal of Immunology, Vol 152, Issue 2 381-387, Copyright © 1994 by American Association of Immunologists
ARTICLES |
I Bacik, JH Cox, R Anderson, JW Yewdell and JR Bennink
Viral Immunology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Under most circumstances, cell surface MHC class I molecules display peptides derived from a cytosolic pool of proteins. The efficient presentation of such peptides requires the functioning of two MHC gene products [TAP1 and TAP2 (transporter-associated with Ag processing 1 and 2)] that form a complex that facilitates transmembrane movement of peptides from the cytosol to the endoplasmic reticulum, the site of peptide association with class I molecules. It has been previously shown that peptides can be presented in a TAP-independent manner in association with HLA A2.1 or H-2 Kd if they are expressed COOH-terminal to an endoplasmic reticulum insertion/signal sequence derived from the adenovirus E3/19K glycoprotein (Anderson et al., 1991. J. Exp. Med. 174: 489; Eisenlohr et al., 1992. Cell 71: 963). We show that: 1) the E3/19K signal sequence greatly enhances the presentation of each of four additional peptides tested in association with H-2 Kb or Kk, 2) the E3/19K signal sequence can be substituted by a signal sequence derived from beta-IFN, and 3) the E3/19K signal sequence does not function when located at the COOH terminus of antigenic peptides. These findings indicate that first, many peptides require TAP for efficient presentation to T cells, second, expression of peptides COOH-terminal to signal sequences is a generally applicable method of bypassing the TAP-dependence of peptide presentation and third, the leader sequence does not act to bypass TAP simply by increasing the hydrophobic nature of peptides.
This article has been cited by other articles:
![]() |
G. J. Renukaradhya, M. A. Khan, D. Shaji, and R. R. Brutkiewicz Vesicular Stomatitis Virus Matrix Protein Impairs CD1d-Mediated Antigen Presentation through Activation of the p38 MAPK Pathway J. Virol., December 15, 2008; 82(24): 12535 - 12542. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Johnstone, S. Guil, M. A. Rico, B. Garcia-Barreno, D. Lopez, J. A. Melero, and M. Del Val Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes J. Gen. Virol., September 1, 2008; 89(9): 2194 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Demirel, Z. Waibler, U. Kalinke, F. Grunebach, S. Appel, P. Brossart, A. Hasilik, R. Tampe, and R. Abele Identification of a Lysosomal Peptide Transport System Induced during Dendritic Cell Development J. Biol. Chem., December 28, 2007; 282(52): 37836 - 37843. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Radcliffe, J. S. Roddick, P. S. Friedmann, F. K. Stevenson, and S. M. Thirdborough Prime-Boost with Alternating DNA Vaccines Designed to Engage Different Antigen Presentation Pathways Generates High Frequencies of Peptide-Specific CD8+ T Cells J. Immunol., November 15, 2006; 177(10): 6626 - 6633. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Renukaradhya, T. J. R. Webb, M. A. Khan, Y. L. Lin, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz Virus-Induced Inhibition of CD1d1-Mediated Antigen Presentation: Reciprocal Regulation by p38 and ERK J. Immunol., October 1, 2005; 175(7): 4301 - 4308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. J. Wong, C. B. Buck, X. Shen, and R. F. Siliciano An Evaluation of Enforced Rapid Proteasomal Degradation as a Means of Enhancing Vaccine-Induced CTL Responses J. Immunol., September 1, 2004; 173(5): 3073 - 3083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Wolkers, N. Brouwenstijn, A. H. Bakker, M. Toebes, and T. N. M. Schumacher Antigen Bias in T Cell Cross-Priming Science, May 28, 2004; 304(5675): 1314 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Paster, M. Kalat, M. Zehetner, and T. Schweighoffer Structural Elements of a Protein Antigen Determine Immunogenicity of the Embedded MHC Class I-Restricted T Cell Epitope J. Immunol., September 15, 2002; 169(6): 2937 - 2946. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Konopitzky, U. Konig, R. G. Meyer, W. Sommergruber, T. Wolfel, and T. Schweighoffer Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the Novel Overexpressed Tumor Antigen Calcium-Activated Chloride Channel 2 J. Immunol., July 1, 2002; 169(1): 540 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Hunziker, B. Grabscheid, R. Zurbriggen, R. Gluck, W. J. Pichler, and A. Cerny In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus Int. Immunol., June 1, 2002; 14(6): 615 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Roberts, V. Sriram, P. M. Spence, M. Gui, K. Hayakawa, I. Bacik, J. R. Bennink, J. W. Yewdell, and R. R. Brutkiewicz Recycling CD1d1 Molecules Present Endogenous Antigens Processed in an Endocytic Compartment to NKT Cells J. Immunol., June 1, 2002; 168(11): 5409 - 5414. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Luckey, J. A. Marto, M. Partridge, E. Hall, F. M. White, J. D. Lippolis, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors J. Immunol., August 1, 2001; 167(3): 1212 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Stefanski, D. Mayerova, S. C. Jameson, and K. A. Hogquist A Low Affinity TCR Ligand Restores Positive Selection of CD8+ T Cells In Vivo J. Immunol., June 1, 2001; 166(11): 6602 - 6607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Norbury, M. F. Princiotta, I. Bacik, R. R. Brutkiewicz, P. Wood, T. Elliott, J. R. Bennink, and J. W. Yewdell Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo J. Immunol., April 1, 2001; 166(7): 4355 - 4362. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Schell, J. D. Lippolis, and S. S. Tevethia Cytotoxic T Lymphocytes from HLA-A2.1 Transgenic Mice Define a Potential Human Epitope from Simian Virus 40 Large T Antigen Cancer Res., February 1, 2001; 61(3): 873 - 879. [Abstract] [Full Text] |
||||
![]() |
A. G. Brickner, E. H. Warren, J. A. Caldwell, Y. Akatsuka, T. N. Golovina, A. L. Zarling, J. Shabanowitz, L. C. Eisenlohr, D. F. Hunt, V. H. Engelhard, et al. The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing J. Exp. Med., January 8, 2001; 193(2): 195 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Pinto, S. Prasad, J. Yewdell, J. Bennink, and S. H. Hughes Restricting Expression Prolongs Expression of Foreign Genes Introduced into Animals by Retroviruses J. Virol., November 1, 2000; 74(21): 10202 - 10206. [Abstract] [Full Text] |
||||
![]() |
T. D. Schell, B. B. Knowles, and S. S. Tevethia Sequential Loss of Cytotoxic T Lymphocyte Responses to Simian Virus 40 Large T Antigen Epitopes in T Antigen Transgenic Mice Developing Osteosarcomas Cancer Res., June 1, 2000; 60(11): 3002 - 3012. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kim, J. W. Yewdell, and W. R. Green Naturally Occurring TAP-Dependent Specific T-Cell Tolerance for a Variant of an Immunodominant Retroviral Cytotoxic T-Lymphocyte Epitope J. Virol., April 15, 2000; 74(8): 3924 - 3928. [Abstract] [Full Text] |
||||
![]() |
U. Gileadi, H. T. Moins-Teisserenc, I. Correa, B. L. Booth Jr., P. R. Dunbar, A. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo Generation of an Immunodominant CTL Epitope Is Affected by Proteasome Subunit Composition and Stability of the Antigenic Protein J. Immunol., December 1, 1999; 163(11): 6045 - 6052. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Corr, A. von Damm, D. J. Lee, and H. Tighe In Vivo Priming by DNA Injection Occurs Predominantly by Antigen Transfer J. Immunol., November 1, 1999; 163(9): 4721 - 4727. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Schell, L. M. Mylin, I. Georgoff, A. K. Teresky, A. J. Levine, and S. S. Tevethia Cytotoxic T-Lymphocyte Epitope Immunodominance in the Control of Choroid Plexus Tumors in Simian Virus 40 Large T Antigen Transgenic Mice J. Virol., July 1, 1999; 73(7): 5981 - 5993. [Abstract] [Full Text] |
||||
![]() |
T.-M. Fu, L. Guan, A. Friedman, T. L. Schofield, J. B. Ulmer, M. A. Liu, and J. J. Donnelly Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge J. Immunol., April 1, 1999; 162(7): 4163 - 4170. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tobery and R. F. Siliciano Cutting Edge: Induction of Enhanced CTL-Dependent Protective Immunity In Vivo by N-End Rule Targeting of a Model Tumor Antigen J. Immunol., January 15, 1999; 162(2): 639 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Leggatt, A. Hosmalin, C. D. Pendleton, A. Kumar, S. Hoffman, and J. A. Berzofsky The Importance of Pairwise Interactions Between Peptide Residues in the Delineation of TCR Specificity J. Immunol., November 1, 1998; 161(9): 4728 - 4735. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Deng, J. Gibbs, I. Bacik, A. Porgador, J. Copeman, P. Lehner, B. Ortmann, P. Cresswell, J. R. Bennink, and J. W. Yewdell Assembly of MHC Class I Molecules with Biosynthesized Endoplasmic Reticulum-Targeted Peptides Is Inefficient in Insect Cells and Can Be Enhanced by Protease Inhibitors J. Immunol., August 15, 1998; 161(4): 1677 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Luckey, G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Proteasomes Can Either Generate or Destroy MHC Class I Epitopes: Evidence for Nonproteasomal Epitope Generation in the Cytosol J. Immunol., July 1, 1998; 161(1): 112 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Anton, H. L. Snyder, J. R. Bennink, A. Vinitsky, M. Orlowski, A. Porgador, and J. W. Yewdell Dissociation of Proteasomal Degradation of Biosynthesized Viral Proteins from Generation of MHC Class I-Associated Antigenic Peptides J. Immunol., May 15, 1998; 160(10): 4859 - 4868. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shi, K. D. Smith, and C. T. Lutz TAP-Independent MHC Class I Peptide Antigen Presentation to Alloreactive CTL Is Enhanced by Target Cell Incubation at Subphysiologic Temperatures J. Immunol., May 1, 1998; 160(9): 4305 - 4312. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kulig, D. Nandi, I. Bacik, J. J. Monaco, and S. Vukmanovic Physical and Functional Association of the Major Histocompatibility Complex Class I Heavy Chain alpha 3 Domain with the Transporter Associated with Antigen Processing J. Exp. Med., March 16, 1998; 187(6): 865 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Fu, L. M. Mylin, T. D. Schell, I. Bacik, G. Russ, J. W. Yewdell, J. R. Bennink, and S. S. Tevethia An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope J. Virol., February 1, 1998; 72(2): 1469 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gabathuler, J. Alimonti, Q.-J. Zhang, G. Kolaitis, G. Reid, and W. A. Jefferies Surrogate Antigen Processing Mediated by TAP-dependent Antigenic Peptide Secretion J. Cell Biol., January 12, 1998; 140(1): 17 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Mosse, L. Meadows, C. J. Luckey, D. J. Kittlesen, E. L. Huczko, C. L. Slingluff Jr., J. Shabanowitz, D. F. Hunt, and V. H. Engelhard The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol J. Exp. Med., January 5, 1998; 187(1): 37 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Snyder, I. Bacik, J. R. Bennink, G. Kearns, T. W. Behrens, T. Bachi, M. Orlowski, and J. W. Yewdell Two Novel Routes of Transporter Associated with Antigen Processing (TAP)-independent Major Histocompatibility Complex Class I Antigen Processing J. Exp. Med., October 6, 1997; 186(7): 1087 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kerkau, I. Bacik, J. R. Bennink, J. W. Yewdell, T. Hunig, A. Schimpl, and U. Schubert The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules J. Exp. Med., April 7, 1997; 185(7): 1295 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Buchholz, P. Scott, and N. Shastri Presentation without Proteolytic Cleavage of Endogenous Precursors in the MHC Class I Antigen Processing Pathway J. Biol. Chem., March 24, 1995; 270(12): 6515 - 6522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kovacsovics-Bankowski and K. Rock A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules Science, January 13, 1995; 267(5195): 243 - 246. [Abstract] [PDF] |
||||
![]() |
A. Komlosh, F. Momburg, T. Weinschenk, N. Emmerich, H. Schild, E. Nadav, I. Shaked, and Y. Reiss A Role for a Novel Luminal Endoplasmic Reticulum Aminopeptidase in Final Trimming of 26 S Proteasome-generated Major Histocompatability Complex Class I Antigenic Peptides J. Biol. Chem., August 3, 2001; 276(32): 30050 - 30056. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |